In addition to epigenetic modifiers (RMDs) and microRNAs; the role of cytokine-inducible SH2-domain-containing protein (CISH or CIS) as anti-tumour and anti-leukaemia activity, also, cannot be denied because of its versatile role in regulating cytokine signalling via sensitizing immune cells. Here, CISH is linked to leukemia.